Literature DB >> 14551822

Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells.

D Koppers-Lalic1, M Rychlowski, D van Leeuwen, F A M Rijsewijk, M E Ressing, J J Neefjes, K Bienkowska-Szewczyk, E J H J Wiertz.   

Abstract

Bovine herpesvirus 1 (BoHV-1), the cause of infectious bovine rhinotracheitis and infectious pustular vulvovaginitis in cattle, establishes a lifelong infection, despite the presence of antiviral immunity in the host. BoHV-1 has been shown to elude the host immune system, but the viral gene products responsible for this interference have not yet been identified. Studies aiming at the identification of BoHV-1-encoded immune evasion genes have been hampered by the lack of bovine-specific immunological reagents. Some of the immune evasion molecules identified for other herpesviruses are host species specific; others can act across the species barrier. In this study, experiments were performed to investigate whether BoHV-1 can infect human cells and interfere with antigen processing and presentation in these cells. A human melanoma cell line, Mel JuSo, appeared to be permissive for BoHV-1 infection. BoHV-1 induced expression of major viral glycoproteins at the surface of these cells and produced progeny virus up to 10(5) plaque forming units per ml. BoHV-1 infection resulted in impaired intracellular transport of human MHC class I molecules and inhibition of human TAP. These data indicate that the BoHV-1-encoded molecule(s) that block antigen presentation in bovine cells are able to interact with homologous components of the human MHC class I presentation pathway. The fact that immune evasion by BoHV-1 can be studied in human cells will facilitate the identification of the BoHV-1 gene products involved in this process. Moreover, the data presented here suggest that the BoHV-1 encoded inhibitors of antigen presentation represent potential immune suppressive agents for use in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551822     DOI: 10.1007/s00705-003-0142-5

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.

Authors:  Danijela Koppers-Lalic; Eric A J Reits; Maaike E Ressing; Andrea D Lipinska; Rupert Abele; Joachim Koch; Marisa Marcondes Rezende; Pieter Admiraal; Daphne van Leeuwen; Krystyna Bienkowska-Szewczyk; Thomas C Mettenleiter; Frans A M Rijsewijk; Robert Tampé; Jacques Neefjes; Emmanuel J H J Wiertz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

Review 2.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

3.  Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M.

Authors:  Andrea D Lipińska; Danijela Koppers-Lalic; Michał Rychłowski; Pieter Admiraal; Frans A M Rijsewijk; Krystyna Bieńkowska-Szewczyk; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts.

Authors:  Mugdha Vasireddi; Julia Hilliard
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus.

Authors:  Marieke C Verweij; Andrea D Lipinska; Danijela Koppers-Lalic; Wouter F van Leeuwen; Jeffrey I Cohen; Paul R Kinchington; Ilhem Messaoudi; Krystyna Bienkowska-Szewczyk; Maaike E Ressing; Frans A M Rijsewijk; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

6.  Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6.

Authors:  Gillian E Dugan; Eric W Hewitt
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

7.  Downregulation of TAP1 and TAP2 in early stage breast cancer.

Authors:  Andrea M Henle; Aziza Nassar; Danell Puglisi-Knutson; Bahaaeldin Youssef; Keith L Knutson
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

8.  Taxonomic patterns in the zoonotic potential of mammalian viruses.

Authors:  Alex D Washburne; Daniel E Crowley; Daniel J Becker; Kevin J Olival; Matthew Taylor; Vincent J Munster; Raina K Plowright
Journal:  PeerJ       Date:  2018-11-28       Impact factor: 2.984

9.  Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP.

Authors:  Danijela Koppers-Lalic; Marieke C Verweij; Andrea D Lipińska; Ying Wang; Edwin Quinten; Eric A Reits; Joachim Koch; Sandra Loch; Marisa Marcondes Rezende; Franz Daus; Krystyna Bieńkowska-Szewczyk; Nikolaus Osterrieder; Thomas C Mettenleiter; Mirjam H M Heemskerk; Robert Tampé; Jacques J Neefjes; Shafiqul I Chowdhury; Maaike E Ressing; Frans A M Rijsewijk; Emmanuel J H J Wiertz
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

10.  Single Pathogen Challenge with Agents of the Bovine Respiratory Disease Complex.

Authors:  Laurel J Gershwin; Alison L Van Eenennaam; Mark L Anderson; Heather A McEligot; Matt X Shao; Rachel Toaff-Rosenstein; Jeremy F Taylor; Holly L Neibergs; James Womack
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.